MOLECULAR AND SEROLOGICAL PROSPECTS FOR SARS-COV2 EPIDEMIOLOGY

The sudden outbreak of the 2019 novel coronavirus "Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China, has affected the healthcare system and economy by its rapidly worldwide spreading The present review intends to describe some of the current molecular and immunological assays used in SARS-CoV-2 detection from an epidemiological perspective, highlighting the importance of rapid test development and improvement In this purpose the database as Databases (NCBI/PubMed, medRxiv) were used for searching, identifying and synthesizing data regarding SARS-CoV2 diagnosis This report presents the optimal assays that can discriminate between different stages of the infection pointing out their utility in diagnosis, treatment, and vaccine development Taken into account SARS-CoV-2 pandemic evolution and the dynamic character of COVID-19 diagnostic assays, the development of a joint effort by the scientific community is necessary for identifying future diagnostic directions that might help the disease management